Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sigma Healthcare's share price for the quarter that ended in Jan. 2024 was $0.4. Sigma Healthcare's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 1,632 Mil. Therefore, Sigma Healthcare's market cap for the quarter that ended in Jan. 2024 was $653 Mil.
Sigma Healthcare's quarterly market cap
declined
from Jan. 2023 ($628 Mil) to Jul. 2023 ($589 Mil) but then
increased
from Jul. 2023 ($589 Mil) to Jan. 2024 ($653 Mil).
Sigma Healthcare's annual market cap
stayed the same
from Jan. 2022 ($628 Mil) to Jan. 2023 ($628 Mil) but then
increased
from Jan. 2023 ($628 Mil) to Jan. 2024 ($653 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sigma Healthcare's Enterprise Value for Today is $1,201 Mil.
Sigma Healthcare Market Cap Historical Data
The historical data trend for Sigma Healthcare's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sigma Healthcare's Market Cap
For the Medical Distribution subindustry, Sigma Healthcare's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sigma Healthcare's Market Cap Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's Market Cap distribution charts can be found below:
* The bar in red indicates where Sigma Healthcare's Market Cap falls into.
Sigma Healthcare Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sigma Healthcare's Market Cap for the fiscal year that ended in Jan. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sigma Healthcare (OTCPK:SIGGF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sigma Healthcare Market Cap Related Terms
Thank you for viewing the detailed overview of Sigma Healthcare's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sigma Healthcare (Sigma Healthcare) Business Description
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SIGGF has been successfully added to your 